Abstract
We report on two patients who developed a secondary acute myeloid leukemia (sAL) after treatment for non-Hodgkin's lymphoma (NHL) with regimens containing low to intermediate doses of VP16. Clinical and hematologic features in these two patients were consistent with epipodophyllotoxin- associated sAL. In one case, a rearrangement of chromosome band 11q23 was detected.
Original language | English |
---|---|
Pages (from-to) | 758-759 |
Number of pages | 2 |
Journal | Haematologica |
Volume | 83 |
Issue number | 8 |
Publication status | Published - 1998 |
Keywords
- Secondary leukemia
- VP16
ASJC Scopus subject areas
- Hematology